Log in to save to my catalogue

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_664872f900d84d57aa08084c56c3b1e4

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022

About this item

Full title

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022

Publisher

China: Lippincott Williams & Wilkins Ovid Technologies

Journal title

Chinese medical journal, 2024-10, Vol.137 (20), p.2429-2436

Language

English

Formats

Publication information

Publisher

China: Lippincott Williams & Wilkins Ovid Technologies

More information

Scope and Contents

Contents

Breast cancer is ranked among the most prevalent malignancies in the Chinese female population. However, comprehensive reports detailing the latest epidemiological data and attributable disease burden have not been extensively documented.
In 2018, high-quality cancer surveillance data were recorded in 700 population-based cancer registries in Ch...

Alternative Titles

Full title

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_664872f900d84d57aa08084c56c3b1e4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_664872f900d84d57aa08084c56c3b1e4

Other Identifiers

ISSN

0366-6999,2542-5641

E-ISSN

2542-5641

DOI

10.1097/CM9.0000000000003278

How to access this item